Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologyHighmark Blueshield Neny diabetic testing Prior Au…
    Ask Trek AI about this page
    CurrentHighmark Blueshield NenyPolicy N/A

    Diabetic Blood Glucose Monitoring Supplies Prior Authorization

    Customize your policy alerts

    Sign up for all Highmark Blueshield Neny policy alerts

    Know when Highmark Blueshield Neny releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document governs prior authorization and clinical information collection for diabetic blood glucose monitoring products and supplies requested for Highmark Blue Shield members; it affects prescribing providers requesting coverage for these products.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyDiabetic Blood Glucose Monitoring Supplies Prior Authorization
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionFax a completed prior authorization form and supporting chart notes to 1-866-240-8123 for requests of diabetic testing supplies.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    6+clinical question items on form
    2 optionspreset day-supply choices

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    fax
    prior auth fax

    Coverage Criteria

    General coverage criteria

    Coverage determination is based on completion of the form demonstrating ALL applicable criteria are met, including diagnosis, treatment details, and clinical need.

    Core requirements: Member has a documented diagnosis of diabetes mellitus (or gestational diabetes if pregnant); treating practitioner has evaluated diabetes control in-person or via Medicare-approved telehealth within the last 6 months and will have follow-up visits every 6 months after the initial prescription; treating practitioner certifies that the member or caregiver has had sufficient training to use the requested product; the quantity of diabetic testing supplies requested is necessary for the member; chart notes are provided to support history of poorly controlled diabetes when indicated; prior authorization form and clinical documentation are submitted to the designated fax number.

    See form items 1,2,2a,3,4,9,10,11 and Prior Authorization instructions

    Hypoglycemia / Insulin-treated criteria

    Additional criteria apply for members with problematic hypoglycemia or who are insulin-treated.

    Hypoglycemia or insulin-related indications: For insulin-treated members: document whether the member uses an insulin pump. For problematic hypoglycemia: document recurrent level 2 hypoglycemic events (more than one event with glucose <54 mg/dL) that persist despite multiple attempts to adjust medications/treatment, OR a history of one level 3 hypoglycemic event (altered mental/physical state requiring third-party assistance), OR problematic hypoglycemia defined by nocturnal hypoglycemia, hypoglycemic unawareness, or frequent/severe episodes (blood glucose <50 mg/dL). Chart notes must be provided to support these events.Level 2: <54 mg/dL; frequent/severe referenced as <50 mg/dL

    See form items 5,6a,7a,7b,8; include supporting chart notes

    Special needs

    Special monitoring needs may qualify a member for specific supplies when documented.

    Special monitoring needs: Member has severe visual impairment (best corrected visual acuity of 20/200 or worse in both eyes) requiring use of a special monitoring system, OR member has an impairment of manual dexterity severe enough to require a special monitoring system. Chart notes should document the impairment and rationale for special equipment.

    See form items 12 and 13; include supporting chart notes

    The form does not list any explicit exclusions. Coverage determination is driven by completion of the clinical questions on the prior authorization form and meeting the stated medical necessity requirements rather than by a separate exclusion section on the form.

    The form includes an operational notice that payment is subject to member eligibility and that authorization does not guarantee payment. Providers should verify member eligibility and benefits prior to assuming payment will be made.

    Coding and Thresholds

    Hypoglycemia thresholds — inv-06
    Level 2 hypoglycemiaGlucose less than 54 mg/dL (3.0 mmol/L)
    Level 3 hypoglycemiaHypoglycemic event characterized by altered mental and/or physical state requiring third-party assistance
    Frequent/severe hypoglycemia thresholdDocument also references frequent/severe hypoglycemia defined as blood glucose less than 50 mg/dL

    Provider Actions and Documentation Requirements

    Prior Authorization

    Prior authorization required — fax or mail completed form with clinical documentation

    A completed prior authorization form and supporting clinical documentation must be submitted for requests for diabetic testing supplies. Fax the completed form and all clinical documentation to 1-866-240-8123 or mail the form as instructed (120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222).

    • Submit a separate form for each medication when applicable.
    • Prescribing physician (PCP or Specialist) should generally complete the form.
    Step Therapy

    Document prior product trials and failures with chart notes

    Provide a list of any other products the member has tried and failed and include chart notes documenting previous failures, intolerance, or contraindications.

    • Use the Product History section to list prior products tried.
    • Attach chart notes that support prior product failures, intolerance, or contraindications.

    Background

    The prior authorization form collects clinical details needed to determine medical necessity for blood glucose monitoring supplies. Required information includes whether the member has a diagnosis of diabetes mellitus, pregnancy/gestational diabetes status, a history of poorly controlled diabetes (with a request to include chart notes when applicable), and whether the treating practitioner has confirmed that the member or caregiver has received sufficient training on use of the requested product. The form also requests prior product history and asks providers to include chart notes to document prior failures, intolerance, or contraindications.

    Definitions

    Problematic hypoglycemia — inv-12
    Nocturnal hypoglycemiaIncluded as an example of problematic hypoglycemia; chart notes should be provided if present
    Hypoglycemic unawarenessListed as a form of problematic hypoglycemia requiring documentation and supporting chart notes
    Frequent/severe hypoglycemiaDefined in the document as blood glucose less than 50 mg/dL (reported as an indication of problematic hypoglycemia); also related to level 2 (<54 mg/dL) and level 3 events
    Severe visual impairment — inv-13
    DefinitionBest corrected visual acuity of 20/200 or worse in both eyes
    Resulting needRequires use of a special monitoring system for blood glucose testing
    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyDiabetic Blood Glucose Monitoring Supplies Prior Authorization
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionFax a completed prior authorization form and supporting chart notes to 1-866-240-8123 for requests of diabetic testing supplies.
    SourceLink
    On This Page
    Coverage CriteriaCoding and ThresholdsProvider Actions and Documentation RequirementsBackgroundDefinitions
    Documentation Required

    Attach chart notes to support clinical history and training

    Include pertinent chart notes to support clinical indications such as history of poorly controlled diabetes, problematic hypoglycemia, insulin pump use, training, or other reasons documented on the form.

    • If history of poorly controlled diabetes is reported, include chart notes (form item 3).
    • Attach documentation of training, insulin pump use, or other clinical details requested on the form.
    • Fax the completed form and all clinical documentation to 1-866-240-8123.
    Denial Risk

    Authorization does not guarantee payment; payment depends on member eligibility

    Payment is subject to the member's eligibility; an authorization does not guarantee payment even if prior authorization is obtained.

    • The submitting provider certifies the information is true and that the requested services are medically indicated, but payment depends on member eligibility.
    DocumentationIf present, include chart notes to support the severe visual impairment claim on the prior authorization form